Your SlideShare is downloading. ×
Endocrine regulation of reproduction
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Endocrine regulation of reproduction


Published on

1 Comment
No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Neuroendocrine Regulation of Reproduction By Dr. Atef Abdel-Hai Khalil Selmi Professor of Obstetrics, Gynecology, & A.I. Faculty of Veterinary Medicine Zagazig University ( 1 )
  • 2. Neuroendocrine Regulation of Reproduction Endocrinology: the branch of science dealing with the study of hormones and their receptors. Neuroendocrinology: A branch of Science dealing with the implication of nervous system in regulation of the endocrine gland functions and many biological activities inside an individual. In neurobiology, the neuron have the unique capacity to transmit information rapidly and reliably over a long distances through a nerve impulse. Such that oxytocin release from posterior pituitary is controlled by sensory nerve impulses derived either from mammary gland or from pelvic plexus. However, pituitary function is regulated through feed back control by neurohormones secreted directly from nerve cells located in the hypothalamus.
  • 3. Mammalian hormones Metabolic hormones: These hormones are necessary for metabolism, growth and development as well as to maintain the general health condition and state of wellbeing of an individual (sense, respirate, feed, move, grow, excrete etc…). They are indirectly involved in some aspects of mammalian reproduction such as GH , Thyroxin, Insulin, Glucagon, etc….. Reproductive hormones: These hormones are derived primarily from the areas of the hypothalamus, pituitary, gonads, placenta, and uterus. They are involved directly in various aspects of reproduction such as oogenesis, spermatogenesis, ovulation, sexual behavior, fertilization, implantation, maintenance of gestation, parturition, lactation, and development of maternal behavior.
  • 4. Neuro-endocrine Regulation of Reproductive Hormones Cerebrum Cerebellum Medulla Oblongata Pituitary Stalk Third Ventricle Pineal Body Optic chiasm Pituitary Gland Hypothalamus
  • 5. Hypothalamic hormones Hypothalamus secretes neurohumoral substance called neurohormones or releasing hormones that influence pituitary synthesis and secretion of the corresponding hormone such that: 1-Gonadotropin hormone–releasing hormone (GnRH) affect synthesis and release of gonadotropin hormones (FSH and LH) from anterior pituitary gland. 2-Thyroid stimulating hormone releasing hormone (TSHRH) affect synthesis and release of Thyroid stimulating hormone (TSH) from anterior pituitary gland. 3-Adrenocoticotropic hormone releasing hormone (ACTHRH) affect synthesis and release of Adrenocoticotropic hormone (ACTH) from anterior pituitary gland. 4-Prolacten inhibiting hormone (PIH) affect synthesis and release of prolactin hormone from anterior pituitary gland. 5-Somatostatin affect synthesis and release of somatotropin
  • 6. 1- Gonadotropin Releasing Hormone)HRnG( Chemistry: GnRH is a decapeptide neurohumoral substance (composed of 10 amino acids) secreted by neurons located in the arcuate nucleus of the hypothalamus, then transported axonally to be stored in the median eminence until appropriate stimulation which causes its release into the hypothalamo- hypophyseal portal circulation. Biological effect: The portal circulation carries the releasing hormone to their receptors (pituitary gonadotrophs) in the anterior lope of pituitary gland, where it stimulates synthesis and secretion of gonadotropic hormones, Follicle stimulating hormone and luteinizing
  • 7. Commercial Preparations: Receptal (5 ml IM) and Fertagyl (2.5 ml IM) are the preparations mostly available that can be used in cows as a single IM injection to stimulate a surge like release of FSH and LH from the anterior pituitary. Therapeutic Uses: 1-Ovarian inactivity. 2-Delayed ovulation. 3-Cystic ovary (twice the dose). 4-Improvement of conception rate. 5-Synchronization of ovulation and resumption of normal estrous cyclicity in postpartum cows. 6-Minimize incidence of cystic ovary in postpartum cows.
  • 8. 2- Oxytocin Hormone Chemistry: It is a peptide neurohumoral substance synthesized by neurons located in supraoptic nucleus of the hypothalamus and transported axonally to be stored in the posterior pituitary. It is released to the general circulation following appropriate nervous stimuli (neural reflex) coming either from pelvic plexus during parturition or from other sense (visual, tactile, or auditory) during lactation.
  • 9. Biological effect: It stimulate smooth muscle contraction in both the genital tract (must be primed by estrogen) and mammary system. Therefore, oxytocin has a definite functions in parturition, milk let-down, transportation of sperm and ova in genital tract, and implicated in the control of luteal regression. Adrenalin block the contractile effect of oxytocin on uterine muscle and myoepithelial cells in mammary tissue. Therefore, widely exited females would develop nervous inhibitory impulse during parturition and would not likely to give a good milk
  • 10. Commercial Preparations: Oxytocin and Cyntocinon are the preparations mostly available that can be used as a single IM or IV injection (10- 15iu or 15-25 iu for small or large animal, respectively )to stimulate milk let-down or to stimulate uterine contraction. Therapeutic Uses : 1- Stimulates milk let-down. 2- Stimulates uterine contraction: A-In parturient females during weak or abolished birth pain. B- to overcome uterine inertia. C- to hasten placental drop. D- to hasten uterine involution. E- to get- red uterine contents in open pyometra. F- to reduce size of the prolapsed uterus.
  • 11. Pituitary Gonadotropin Hormones Chemistry: Gonadotropins are glycoprotein in nature (carbohydrates-containing proteins), that are secreted from pituitary gonadotrophs under the stimulatory effect of hypothalamic GnRH. They are composed of two polypeptide subunits,α and β that bound in noncovalent association of very high affinity. Both FSH and LH wthin the same species have a common α subunit that possess the same amino acids sequence (species specific), but β subunit is a hormone specific subunit that has a different amino acids sequence. Whereas, Carbohydrate groups located in both subunit influence the stability and ability of the hormone to combine with and activate their receptor sites in testis and ovary. However, half-life of glycoprotein hormones in circulation depends upon their sialic acid content.
  • 12. Characteristics of gonadotropic hormones Half-lifeSialic acid Carbo- hydrate Molecular weight Hormone < 30 min.1 – 2%12 -24 % 28 - 34000LH 2 hr.5 %25 %32 - 37000FSH 11 hr.8.5 %32%38000HCG 26 hr.10.4 %48 %68000PMS (eCG)
  • 13. A- Follicle stimulating hormone (FSH(: Biological effect: 1-Stimulate folliculogenesis: It reach the specific receptor sites on granulosa cells surrounding the primordial follicle and stimulate their mitosis with a consequent proliferation and follicular fluid formation that result in increased follicular size and development. 2-Stimulate luteinization : by increasing LH receptors on both granulosa cells and thecal cells. 3- Stimulate steroidogenesis: the steroidogenic activity of the follicle depends on FSH and LH that acting on both granulosa cells (estrogen) and thecal cells (androgen) with a consequent increase in follicular estrogen production (two cell theory). 4- Stimulate follicular maturation: a certain balance
  • 14. Steroid cocentration in follicular fluid in relation to follicular development and atresia Testosterone (Pmol/ml) Progesterone (Pmol/ml) Estradiol (Pmol/ml) Follicular diameter (mm) 280401402-3 (small, nonatretic) 701501003-6 (large, nonatretic) 1901208603-6 (large, atretic)
  • 15. Commercial Biological preparations: - Anteron -Anterior pituitary extract. - Prolan A -Pregnant mare serum gonadotropin (PMS). - Gestyl Or equine chorionic gonadotropin (eCG). -Folligon -Menopausal urine gonadotropin (MUG). Therapeutic dose: -200 - 500 i.u. for Small animal. -500 -1500 i.u. for large animal. -Over dosing causes super-ovulation.
  • 16. :Therapeutic uses - It is used mainly to activates the ovary in cases of ovarian inactivity or to induce follicular growth either for super-ovulation purposes or for out-of-seasone breeding. Repeated injections are required owing to short half-life. - Repeated administration has a refractory results due to antibodies formation that neutralize the injected hormone. Moreover, anaphylactic reaction may developed in treated cases.
  • 17. (LH):B- luteinizing hormone Biological effect: 1- Stimulate follicular steroidogenesis: the steroidogenic activity of the follicle depends on FSH and LH that acting on both granulosa cells (estrogen) and thecal cells (androgen) with a consequent increase in follicular estrogen production (two cell theory), since androgen well be aromatized to estrogen during diffusion through granulosa cells. 2- Stimulate follicular and ovum maturation. 3- Induce ovulation by increasing intrafollicular concentration of proteolytic system ( proteolytic enzymes, collagenase-like enzyme, plasminogen
  • 18. Commercial Biological preparations : -Premogenyl - Human chorionic gonadotropin(HCG) -Prolan B -Pregnyl Therapeutic dose -500–1000 i.u. for small animals -1000-5000 i.u. for large animals Therapeutic uses: 1- Luteinization of follicular cysts (cystic ovary). 2-Induction of ovulation. 3-Delayed ovulation. 4-Repeated administration has a refractory results due to antibodies formation that neutralize the injected hormone.
  • 19. C- prolactin or Leutotrophic hormone(LTH(: Chemistry: Its molecules are very similar to growth hormone. It is composed of single polypeptide chain that contains 198 amino acid with a molecular weight of 27000.  It have specific receptor sites on ovary, liver, adrenal gland, and mammary gland. The wide spread of prolactin receptors and wide range of action ( osmoregulation, metabolic, and reproduction ) classify prolactin as metabolic rather than gonadotropic hormone.
  • 20. Biological effect: It has mammogenic action: inducing mammary growth. It has lactogenic action: initiates milk secretion after parturition. It has galactogenic action: stimulates continuation of established milk secretion. It has luteotropic action and increased number of LH receptors on the ovary. It maintain CL function with consequent cessation of estrous cycle in high lactating cows. It stimulate maternal behavior in mature females.
  • 21. Ovarian Steroid hormones 1-Estrogen : Chemistry: Plasma cholesterol is the precursor of steroid nucleus (cyclopentano-perhydro-phenantherin nucleus) . Conversion of cholesterol to steroid hormone is accelerated by LH through cAMP. Biological action: Growth of sexual organs through its anabolic effect. Development of secondary sexual characters in females. Induce the clinical and behavioral signs of estrum. induce proliferation of the duct system of the udder. Favors calcium deposition in long bones. Prepare receptors to oxytocin. Favors deposition of glycogen in endometrial glands.
  • 22. Commercial preparations: -Diethyl stibesterol -Premarine. -Cyren B . -Triphynyl etheline. -Hexesterol. -Folone. They are oily preparations and injected i.m. or s.c. Therapeutic dose: -Small animals Up to 20 mg. -Large animals Up to 50 mg. -Average dose 30 mg.
  • 23. Therapeutic uses: 1. Induce abortion in case of unwanted pregnancy. 2.To open cervical canal to get red of uterine contents during treatment of closed pyometra or mummified fetus. 3.To treat ovarian inactivity through injection of small minute doses to initiate FSH secretion. 4. To induce hormonal castration and fattening. 5- To help in treatment of vaginal prolapse.
  • 24. Disadvantages of estrogen application: 1- Reduce milk yield and even stop its secretion. 2- Excessive amounts causes relaxation of the pelvic ligaments and may leads to vaginal or rectal prolapse. 3. Prolonged use might causes nymphomania, cassation of estrous cycle and atrophy of the ovary due to stopping FSH secretion and release.
  • 25. 2-Progesterone Biological action: 1- Inhibit folliculogenesis. 2- Proliferate the alveolar system of mammary gland. 3- Necessary to maintain pregnancy. 4-Favors deposition of glycogen in endometrial glands and stemulate uterine milk secretion. 5-Anabolic steroid .
  • 26. Commercial preparation: Methyl acetoxy progesterone (MAP). Chlormadinone acetate progesterone (CAP). Medroxy progesterone acetate (MPA). Therapeutic doses: Small animals 10-20 mg Large animals 50 mg Therapeutic uses: 1. To prevent or control habitual abortion. 2. Synchronization of estrous. 3. In cystic ovary (nymphomania) to counter effect of estrogen. 4. Vaginal prolapse .
  • 27. 3-Bradykinin It is a polypeptide hormone. It is found in the follicular fluid of Graffian follicle of bovine, rabbit and human.  It reaches the fallopian tube after ovulation and help trapping of the ovum by infundibulum.
  • 28. 4-Relaxin: It is a polypeptide in nature secreted from C.L. in the late pregnancy, and by the placenta and uterus.  It aids in the dilatation of the cervix and causes relaxation of the pelvic ligaments, separation of the symphysis pelvis thereby preparing the birth way for the act of parturition.
  • 29. Mechanism of Hormonal Control 1-Neurohumoral mechanism : A neurohumoral substance reaching the endocrine gland through circulating blood such as Gonadotropin releasing hormone secreted from the hypothalamus and reaching anterior pituitary gland through hypothalamo-hypophysial portal circulation to stimulate synthesis and secretion of Gonadotropin. 2-Nervous mechanism : An appropriate nervous impulse is necessary to release the hormones such as nervous impulse necessary to release oxytocin from posterior pituitary gland following visual or tactile or auditory stimulation during milking. Vaginal stimulation in conditioned ovulators (she camel and
  • 30. 3-Feed-back mechanism (servo-mechanism): such that reported btween Gonadotropin hormones and estrogen hormone. FSH stimulate follicular growth and stimulate steroidogenesis. FSH secretion will be decline or inhibited as the follicle reaching the mature size and secrete high amounts of estrogen hormone ( negative feed back regulation), but high level of estrogen will stimulate release of high amounts of LH necessary to induce ovulation (positive feed back regulation). Therefore, a negative feed back is found between estrogen and FSH, but a positive feed back is developed between estrogen and LH. In another wards, estrogen will feed back to anterior pituitary gland to inhibit secretion of FSH
  • 31. Mechanism of Hormonal Action Hormone: An organo-chemical substance produced by certain specialized cells (endocrine gland), reach their receptors sites on the target organ or tissues through circulation (blood or lymph), with the resultant stimulation as follows: 1-Hormone binds to its specific receptors located on the plasma membrane of the target cell (1st messenger to plasma membrane. 2- Then activates Adenylat Cyclase Enzyme that change cATP to cAMP (2nd messenger to nuclear DNA). 3-Nuclear DNA transcript the message and produce mRNA (3rd messenger to cytoplasm) that activates protein kinase enzyme involved in the physiological function of the target cell (produce hormone or enzymes or secretions).
  • 32. Protein/Peptide Hormones ATP = Adenosine Triphosphate cAMP = Cyclic Adenosine Monophosphate PP = Pyrophosphate Granulosa Cell FSH Enzyme Cytoplasm DNA Steroid enzymes Estrogen synthesis Phosphodiesterase Inactivates by conversion Caffeine inhibits enzyme and allows prolonged activation Capillary Protein Hormone Hormone Receptor Adenylate Cyclase ATP cAMP + PP Protein Kinase 5’AMP NucleusmRNA Protein Released from cell Bilaminar Cell Membrane
  • 33. Steroid Hormones Uterine Glandular Epithelial Cell Progesterone Diffuses in cytoplasm Secretion into uterine lumen Steroid Capillary Release from blood circulation Steroid DNA Nucleus Receptor mRNA Rough Endoplasmic Reticulum Protein Synthesis Bilaminar Cell Membrane Chromatin
  • 34. Endometrial hormones Prostaglandin Chemistry: Arachidonic fatty acid is the precursor of Prostaglandin series ( A, B, C, D, E, F, G, H). Biosynthesis of Prostaglandin (PG) is mediated by a microsomal complex of enzymes (prostaglandin synthetase enzymes). These enzymes are demonstrated in a wide number of organs, but the rate and type of prostaglandin biosynthesis differ widely among organs. Prostaglandin E (PGE) is the predominant product in many tissues, but PGF is the product frequently identified in the genital tract.
  • 35. :Synthesis and secretion  Progesterone stabilize phospholipase enzyme that is responsible for hydrolysis of phospholipids. However, estrogen labilize this enzyme. Thus, decline in progesterone cocentration in the plasma and ascendence of estrogen during the terminal period of pregnancy are responsible to induce release of such enzyme to induce hydrolysis of phospholipids and produce the precursor of PG (arachidonic fatty acid).  Increased estrogen concentration during the last 15 days of pregnancy was associated with increased PGF2α concentration in both fetal fluid and endometrial caruncles.
  • 36. :Mode of action on smooth muscle PGF (smooth muscle contraction) often display the opposite biologic activity to that of PGE (smooth muscle relaxation), but PGF can be converted directly to PGE and vice versa. The consequent biologic activity can also be reversed or modified by direct conversion. PGF2α has an ecopolic effect and luteolytic effect. It increases calcium release from sarcoplasmic reticula, and calcium-induced activation of glycogen phosphorylase system through cAMP with cosequent formation of glucose (nessesary to support the metabolic needs of the contractile muscle). PGE2 induce smooth muscle relaxation through Guanilate cyclase activity (inhibition) through cGMP.
  • 37. :Commercial preparations Estrumate (2 ml IM), Lutalyse (5 ml IM), Illerine (2.5 ml IM), Prosolvine (2 ml IM), Equamate (2 ml IM for mares). Therapeutic uses: 1-Estrus synchronization (Three programs or regimens): A-Clinical examination, detection of CL, single dose, breeding for responders. B-Single dose heat, followed by another dose after 12 days from the first injection for refractory cases. C-Two successive injection with 12 days intervals, then application of two successive insemination. 2-Induction of parturition. 3-Induction of abortion. 4-Treatment of pyometra, endometritis, and mummified or macerated fetus (opening the cervix and repeated estrum).